Targeted elimination of <i>Fusobacterium nucleatum</i> alleviates periodontitis

Abstract

FP-100 effectively eliminates <i>F.</i> <i>nucleatum</i> from oral microbiota and significantly reduces bone loss in a mouse periodontitis model, demonstrating its potential as a targeted therapeutic agent for periodontal disease.